EOG Resources vs Occidental Petroleum
EOG and OXY side by side, both in crude petroleum and natural gas. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EOG and OXY compare
EOG Resources is the larger company, worth 1.4 times as much as Occidental Petroleum ($86.8B against $64.0B).
On earnings, Occidental Petroleum is cheaper: it trades at 9.9× trailing earnings, against 12.9× for EOG Resources.
EOG Resources grew revenue faster over the last twelve months (19.1% versus 7.3% for Occidental Petroleum).
Both pay dividends: EOG Resources yields 2.5% and Occidental Petroleum 1.6%.
EOG Resources scores higher on the StockData Score (12 against 10 for Occidental Petroleum), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EOG | OXY |
|---|---|---|
| Size and price | ||
| Market cap | $86.8B | $64.0B |
| Share price | $165.54 | $64.00 |
| Change, 1 year | 56.2% | 57.7% |
| Change, 5 years | 74.0% | 91.5% |
| Beta (5Y) | 0.52 | 0.40 |
| Employees | 3,400 | 6,793 |
| StockData Score | ||
| Total score | 12 (better) | 10 |
| Valuation score | 0 | 4 (better) |
| Growth score | 1 | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 6 (better) | 4 |
| Dividend score | 1 | 1 |
| Valuation | ||
| P/E | 12.9× | 9.9× (better) |
| P/S | 3.2× | 3.0× (better) |
| P/B | 2.7× | 1.5× (better) |
| EV/EBITDA | 6.5× | 5.9× (better) |
| P/FCF | – | 13.3× |
| FCF yield | – | 7.5% |
| Fair value | $163.57 | $73.13 |
| Margin of safety | −1.2% | 12.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 19.1% (better) | 7.3% |
| Revenue growth, 5Y average | 15.5% (better) | 3.9% |
| Net income growth (TTM) | 20.0% | – |
| EPS growth (TTM) | 24.6% | 278% (better) |
| Profitability | ||
| Operating margin | 32.9% | – |
| Net margin | 25.4% | – |
| FCF margin | – | 22.1% |
| Return on equity | 22.5% | – |
| Return on invested capital | 22.1% | – |
| Financial health | ||
| Debt / equity | 0.25 (better) | 0.33 |
| Net debt / EBITDA | 0.22 (better) | 0.76 |
| Interest coverage | 33.0× | – |
| Current ratio | 1.85 (better) | 1.41 |
| Altman Z-score | 4.26 (better) | 1.81 |
| Piotroski F-score | 4 | – |
| Dividends and buybacks | ||
| Dividend yield | 2.5% (better) | 1.6% |
| Years of dividend growth | 1 | 4 (better) |
| Dividend growth, 5Y average | 21.6% (better) | 3.2% |
| Buyback yield | 3.3% (better) | −0.33% |
| Shareholder yield | 5.8% (better) | 1.3% |
| Ownership | ||
| Held by institutions | 96.5% | 83.6% |
| Held by insiders | 0.23% | 0.38% |
| Insider net buying, 12 months | −$10.8M | $445K (better) |
| Superinvestors holding | 2 | 2 |
| Short interest, % of float | 3.1% | 2.2% |
Go deeper
- EOG stock overview
- EOG income statement
- EOG valuation and score
- OXY stock overview
- OXY income statement
- OXY valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.